ACCOUNTS - Final Accounts

Registered number: 09642902

VEDASKIN MEDICAL SERVICES LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

VEDASKIN MEDICAL SERVICES LIMITED

COMPANY INFORMATION

Director	Dr J Patel


Registered number	09642902


Registered office	39 Glean Close
	Broughton
	Astley
	England
	LE9 6WY


Accountants	EQ Accountants Limited
	Chartered Accountants
	Pentland House
	Saltire Centre
	Glenrothes
	Fife
	KY6 2AH

VEDASKIN MEDICAL SERVICES LIMITED

REGISTERED NUMBER: 09642902

STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2025

		2025		2024
		£		£

Fixed assets
Tangible assets	5		2,195		4,022
			2,195		4,022
Current assets
Stocks		1,500		3,600
Debtors: amounts falling due within one year	6	5,000		695
Cash at bank and in hand		37,061		41,907
		43,561		46,202
Creditors: amounts falling due within one year	7	(4,574)		(8,362)
Net current assets			38,987		37,840
Total assets less current liabilities			41,182		41,862
Provisions for liabilities
Deferred tax		(417)		(764)
			(417)		(764)
Net assets			40,765		41,098

Capital and reserves
Called up share capital	8	5,100	5,100
Profit and loss account		35,665	35,998
		40,765	41,098

Page 1

VEDASKIN MEDICAL SERVICES LIMITED

REGISTERED NUMBER: 09642902

STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 DECEMBER 2025

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by by:

Dr J Patel

Director

Date: 7 May 2026

The notes on pages 3 to 7 form part of these financial statements.

Page 2

VEDASKIN MEDICAL SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

1.	General information

The Company is limited by shares and incorporated in England; Registration Number 09642902. The registered office address is 39 Glean Close, Broughton, Astley, England, LE9 6WY.
The financial statements are presented in Sterling which is the functional currency of the company and rounded to the nearest £.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Sale of goods

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:

∙the Company has transferred the significant risks and rewards of ownership to the buyer;

∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;

∙the amount of turnover can be measured reliably;

∙it is probable that the Company will receive the consideration due under the transaction; and

∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of turnover can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

VEDASKIN MEDICAL SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.3

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:

∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and

∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

2.4

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

The estimated useful lives range as follows:

Trademarks

years straight line

Page 4

VEDASKIN MEDICAL SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

				Equipment	-	20% straight line
				Office equipment	-	33.33% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

2.6

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Statement of financial position when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

2.7

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

Page 5

VEDASKIN MEDICAL SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

4.	Intangible assets

		Trademarks
		£
	Cost
	At 1 January 2025	2,331
	At 31 December 2025	2,331
	Amortisation
	At 1 January 2025	2,331
	At 31 December 2025	2,331
	Net book value
	At 31 December 2025	-
	At 31 December 2024	-

5.	Tangible fixed assets

	Equipment	Office Equipment	Total
	£	£	£
Cost or valuation
At 1 January 2025	8,781	2,786	11,567
At 31 December 2025	8,781	2,786	11,567
Depreciation
At 1 January 2025	5,328	2,217	7,545
Charge for the year on owned assets	1,258	569	1,827
At 31 December 2025	6,586	2,786	9,372
Net book value
At 31 December 2025	2,195	-	2,195
At 31 December 2024	3,453	569	4,022

Page 6

VEDASKIN MEDICAL SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

Debtors

					2025	2024
					£	£


Trade debtors	5,000	695

7.	Creditors: Amounts falling due within one year
		2025	2024
		£	£

Other taxation and social security	1,430	2,835
Other creditors	624	3,263
Accruals and deferred income	2,520	2,264
	4,574	8,362

8.	Share capital
		2025	2024
		£	£

Allotted, called up and fully paid

4,000 (2024 - 4,000) Ordinary A shares of £1.00 each	4,000	4,000
1,000 (2024 - 1,000) Ordinary B shares of £1.00 each	1,000	1,000
50 (2024 - 50) Ordinary E shares of £1.00 each	50	50
50 (2024 - 50) Ordinary F shares of £1.00 each	50	50

	5,100	5,100

Page 7